Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Change in Receivables (2016 - 2025)

Historic Change in Receivables for AtriCure (ATRC) over the last 16 years, with Q3 2025 value amounting to -$3.0 million.

  • AtriCure's Change in Receivables fell 23471.44% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year increase of 14977.92%. This contributed to the annual value of $8.3 million for FY2024, which is 1591.37% down from last year.
  • Latest data reveals that AtriCure reported Change in Receivables of -$3.0 million as of Q3 2025, which was down 23471.44% from $2.2 million recorded in Q2 2025.
  • AtriCure's Change in Receivables' 5-year high stood at $8.0 million during Q1 2022, with a 5-year trough of -$3.0 million in Q3 2025.
  • Its 5-year average for Change in Receivables is $2.1 million, with a median of $2.2 million in 2025.
  • Its Change in Receivables has fluctuated over the past 5 years, first soared by 2320000.0% in 2023, then crashed by 23471.44% in 2025.
  • AtriCure's Change in Receivables (Quarter) stood at -$496000.0 in 2021, then soared by 100.81% to $4000.0 in 2022, then soared by 23200.0% to $932000.0 in 2023, then skyrocketed by 550.54% to $6.1 million in 2024, then crashed by 149.3% to -$3.0 million in 2025.
  • Its last three reported values are -$3.0 million in Q3 2025, $2.2 million for Q2 2025, and $2.7 million during Q1 2025.